Global CAR-T Cell Service Market 2025 by Company, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global CAR-T Cell Service market size was valued at US$ 1415 million in 2024 and is forecast to a readjusted size of USD 2021 million by 2031 with a CAGR of 5.3% during review period.
CAR-T (Chimeric Antigen Receptor T-cell) therapy is an innovative and personalized form of immunotherapy designed to treat certain types of cancers, particularly blood cancers like leukemia and lymphoma. The development of CAR-T cells involves a complex process that requires several specialized services. A comprehensive CAR-T cell development service covers the entire pipeline from initial consultation and CAR design through to clinical trials and post-approval support. It is tailored to meet the unique needs of each patient's cancer type, the desired target antigen, and the specific requirements of regulatory agencies.
The CAR - T cell service industry is currently experiencing rapid development and faces many opportunities and challenges. Driven by the increasing incidence of cancer and the continuous advancement of technology, the industry has broad development prospects. Technologically, the research and development of new CAR - T cell technologies is accelerating. The industry is committed to improving the efficacy and safety of CAR - T cells in treating solid tumors, such as by adding controllable suicide genes and pro - inflammatory cytokines to the CAR structure. In addition, the exploration of CAR - T cell therapy in the treatment of autoimmune diseases has also become a hot topic, with many clinical trials ongoing. Commercially, there are currently 11 CAR - T cell therapy drugs approved globally, with sales continuing to increase. However, the high price of drugs and the narrow patient population limit the expansion of the market scale. Therefore, reducing costs and expanding the patient population are the main development directions of enterprises. In the future, with the continuous progress of technology and the expansion of application scenarios, the CAR - T cell service industry is expected to achieve greater development and bring more hope to patients with cancer and autoimmune diseases.
This report is a detailed and comprehensive analysis for global CAR-T Cell Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global CAR-T Cell Service market size and forecasts, in consumption value ($ Million), 2020-2031
Global CAR-T Cell Service market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global CAR-T Cell Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global CAR-T Cell Service market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CAR-T Cell Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CAR-T Cell Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aurigene Pharmaceutical Services Ltd, Cellipont Bioservices, ProBio, Creative Biolabs, Charles River Laboratories, Cytiva, Sino Biological, Inc, Miltenyi Biotec, ProMab Biotechnologies, Inc, Creative Biogene, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
CAR-T Cell Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Development Services
Manufacturing Services
Other
Market segment by Application
Clinical Research
Clinical Treatment
Other
Market segment by players, this report covers
Aurigene Pharmaceutical Services Ltd
Cellipont Bioservices
ProBio
Creative Biolabs
Charles River Laboratories
Cytiva
Sino Biological, Inc
Miltenyi Biotec
ProMab Biotechnologies, Inc
Creative Biogene
BPS Bioscience, Inc
Reaction Biology
Cusabio Technology LLC
Oncodesign Services
ACROBiosystems
Kite Pharma, Inc
sartorius
WuXi ATU Co
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CAR-T Cell Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CAR-T Cell Service, with revenue, gross margin, and global market share of CAR-T Cell Service from 2020 to 2025.
Chapter 3, the CAR-T Cell Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and CAR-T Cell Service market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CAR-T Cell Service.
Chapter 13, to describe CAR-T Cell Service research findings and conclusion.
CAR-T (Chimeric Antigen Receptor T-cell) therapy is an innovative and personalized form of immunotherapy designed to treat certain types of cancers, particularly blood cancers like leukemia and lymphoma. The development of CAR-T cells involves a complex process that requires several specialized services. A comprehensive CAR-T cell development service covers the entire pipeline from initial consultation and CAR design through to clinical trials and post-approval support. It is tailored to meet the unique needs of each patient's cancer type, the desired target antigen, and the specific requirements of regulatory agencies.
The CAR - T cell service industry is currently experiencing rapid development and faces many opportunities and challenges. Driven by the increasing incidence of cancer and the continuous advancement of technology, the industry has broad development prospects. Technologically, the research and development of new CAR - T cell technologies is accelerating. The industry is committed to improving the efficacy and safety of CAR - T cells in treating solid tumors, such as by adding controllable suicide genes and pro - inflammatory cytokines to the CAR structure. In addition, the exploration of CAR - T cell therapy in the treatment of autoimmune diseases has also become a hot topic, with many clinical trials ongoing. Commercially, there are currently 11 CAR - T cell therapy drugs approved globally, with sales continuing to increase. However, the high price of drugs and the narrow patient population limit the expansion of the market scale. Therefore, reducing costs and expanding the patient population are the main development directions of enterprises. In the future, with the continuous progress of technology and the expansion of application scenarios, the CAR - T cell service industry is expected to achieve greater development and bring more hope to patients with cancer and autoimmune diseases.
This report is a detailed and comprehensive analysis for global CAR-T Cell Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global CAR-T Cell Service market size and forecasts, in consumption value ($ Million), 2020-2031
Global CAR-T Cell Service market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global CAR-T Cell Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global CAR-T Cell Service market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CAR-T Cell Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CAR-T Cell Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aurigene Pharmaceutical Services Ltd, Cellipont Bioservices, ProBio, Creative Biolabs, Charles River Laboratories, Cytiva, Sino Biological, Inc, Miltenyi Biotec, ProMab Biotechnologies, Inc, Creative Biogene, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
CAR-T Cell Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Development Services
Manufacturing Services
Other
Market segment by Application
Clinical Research
Clinical Treatment
Other
Market segment by players, this report covers
Aurigene Pharmaceutical Services Ltd
Cellipont Bioservices
ProBio
Creative Biolabs
Charles River Laboratories
Cytiva
Sino Biological, Inc
Miltenyi Biotec
ProMab Biotechnologies, Inc
Creative Biogene
BPS Bioscience, Inc
Reaction Biology
Cusabio Technology LLC
Oncodesign Services
ACROBiosystems
Kite Pharma, Inc
sartorius
WuXi ATU Co
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CAR-T Cell Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CAR-T Cell Service, with revenue, gross margin, and global market share of CAR-T Cell Service from 2020 to 2025.
Chapter 3, the CAR-T Cell Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and CAR-T Cell Service market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CAR-T Cell Service.
Chapter 13, to describe CAR-T Cell Service research findings and conclusion.
Table of Contents
133 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
- 10 Middle East & Africa
- 11 Market Dynamics
- 12 Industry Chain Analysis
- 13 Research Findings and Conclusion
- 14 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
